Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zostavax and Shingrix in RA Patients Using Abatacept
NCT03604406Phase 2Completed
- Sponsor
- Kevin Winthrop
- Start
- May 2014
- Primary completion
- Jun 2024
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of zoster vaccine, live and Zoster vaccine recombinant in herpes zoster (HZ) (4 arms), sponsored by Kevin Winthrop. Primary endpoints: Change in ELISPOT response at 1 year and Change in IgG titer at 1 year. Started May 2014; status: completed.
02
Drugs
zoster vaccine, liveZoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT03604406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03604406.